Skip to the page

Data / Form D filings / Florey Biosciences, Inc.

Florey Biosciences, Inc.: Form D filing

Florey Biosciences, Inc., a biotechnology company in Cambridge, MA, filed a Form D with the SEC in 2025. The latest, on April 29, 2025, reports $1.4 million sold of a $4.4 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
160 ALEWIFE BROOK PKWY #1378, Cambridge, MA, 02138
Phone
(603) 306-1237
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2066011

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 29, 2025New notice$4,400,000$1,400,000$3,000,0001Apr 10, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Peter Fernando HuttDirector
Raphael Fernando GayetExecutive Officer
Mark Fernando SmithDirector
Andres Fernando Cubillos RuizExecutive Officer, Director

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of Apr 28, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Florey Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.